Antimicrobial agents' utilization and cost pattern in an Intensive Care Unit of a Teaching Hospital in South India
Nikhilesh Anand, I. M. Nagendra Nayak, M. V. Advaitha, Noble J. Thaikattil, Kiran A. Kantanavar, Sanjit Anand
Antimicrobial agents, cost analysis, DDD/ATC, drug utilization study, Intensive Care Unit
Citation Information :
Anand N, Nagendra Nayak IM, Advaitha MV, Thaikattil NJ, Kantanavar KA, Anand S. Antimicrobial agents' utilization and cost pattern in an Intensive Care Unit of a Teaching Hospital in South India. Indian J Crit Care Med 2016; 20 (5):274-279.
Background and Aims: High utilization and inappropriate usage of antimicrobial agents (AMAs) in an Intensive Care Unit (ICU) increases resistant organisms, morbidity, mortality, and treatment cost. Prescription audit and active feedback are a proven method to check the irrational prescription. Measuring drug utilization in DDD/100 bed-days is proposed by the WHO to analyze and compare the utilization of drugs. Data of AMAs utilization are required for planning an antibiotic policy and for follow-up of intervention strategies. Hence, in this study, we proposed to evaluate the utilization pattern and cost analysis of AMA used in the ICU.
Methodology: A prospective observational study was conducted for 1 year from January 1, 2014, to December 31, 2014, and the data were obtained from the ICU of a tertiary care hospital. The demographic data, disease data, relevant investigation, the utilization of different classes of AMAs (WHO-ATC classification) as well as individual drugs and their costs were recorded.
Results: One thousand eight hundred and sixty-two prescriptions of AMAs were recorded during the study period with an average of 1.73 ± 0.04 prescriptions/patient. About 80.4% patients were prescribed AMAs during admission. Ceftriaxone (22.77%) was the most commonly prescribed AMA followed by piperacillin/tazobactam (15.79%), metronidazole (12%), amoxicillin/clavulanic acid (6.44%), and azithromycin (4.34%). Ceftriaxone, piperacillin/tazobactam, metronidazole, and linezolid were the five maximally utilized AMAs with 38.52, 19.22, 14.34, 8.76, and 8.16 DDD/100 bed-days respectively. An average cost of AMAs used per patient was 2213 Indian rupees (INR).
Conclusion: A high utilization of AMAs and a high cost of treatment were noticed which was comparable to other published data, though an increased use of newer AMAs such as linezolid, clindamycin, meropenem, colistin was noticed.
Khardori N. Antibiotics – Past, present, and future. Med Clin North Am 2006;90:1049-76.
Krivoy N, El-Ahal WA, Bar-Lavie Y, Haddad S. Antibiotic prescription and cost patterns in a general intensive care unit. Pharm Pract (Granada) 2007;5:67-73.
Røder BL, Nielsen SL, Magnussen P, Engquist A, Frimodt-Møller N. Antibiotic usage in an intensive care unit in a Danish University Hospital. J Antimicrob Chemother 1993;32:633-42.
Marschner JP, Thürmann P, Harder S, Rietbrock N. Drug utilization review on a surgical intensive care unit. Int J Clin Pharmacol Ther 1994;32:447-51.
Dukes MN. Drug utilization studies. Methods and uses. Introduction. WHO Reg Publ Eur Ser 1993;45:1-4.
Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, et al. Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Antimicrob Chemother 1997;39:527-35.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment; 2013. p. 1-284. Available from: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf [Last accessed 2015 Sep 11].
Shankar PR, Partha P, Dubey AK, Mishra P, Deshpande VY. Intensive care unit drug utilization in a teaching Hospital in Nepal. Kathmandu Univ Med J (KUMJ) 2005;3:130-7.
John LJ, Devi P, John J, Guido S. Drug utilization study of antimicrobial agents in medical intensive care unit of a tertuart care hospital. Asian J Pharm Clin Res 2011;4:81-4.
Amit GS. Drug use evaluation study in a tertiary care corporate hospital with special reference to use of antibiotics in ICU department. Int J Adv Pharm Biol Chem 2013;2:179-89.
Biswal S, Mishra P, Malhotra S, Puri GD, Pandhi P. Drug utilization pattern in the intensive care unit of a tertiary care hospital. J Clin Pharmacol 2006;46:945-51.
Smythe MA, Melendy S, Jahns B, Dmuchowski C. An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 1993;21:1319-23.
Badar VA, Navale SB. Study of prescribing pattern of antimicrobial agents in medicine intensive care unit of a teaching hospital in Central India. J Assoc Physicians India 2012;60:20-3.
Williams A, Mathai AS, Phillips AS. Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India. J Pharm Bioallied Sci 2011;3:531-6.
Stratton CW 4th, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: Practical application and clinical utility. Clin Ther 1993;15 Suppl A: 12-20.
Hanssens Y, Ismaeil BB, Kamha AA, Elshafie SS, Adheir FS, Saleh TM, et al. Antibiotic prescribing pattern in a medical intensive care unit in Qatar. Saudi Med J 2005;26:1269-76.
Usluer G, Ozgunes I, Leblebicioglu H; Turkish Antibiotic Utilization Study Group. A multicenter point-prevalence study: Antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob 2005;4:16.
Adiga MN, Alwar MC, Pai MR, Adiga US. Pattern of antimicrobial agents use in hospital deliveries: A prospective comparative study. Online J Health Allied Sci 2009;8:10. Available from: [Last accessed 2015 Oct 12].
Patil PH, Kuchake VG, Ajay K, Pitambar D, Surana S. Evaluation of drug utilization especially antimicrobial agent pattern in tertiary care unit hospital. Int J Community Pharm 2009;2:13-23.
Farooqi R, Afridi M, Farooqi J. Use of antibiotics in hospitalized adult patients: An experience from NWFP. Rawal Med J 2005;30:16-8.
Fonseca LG, de Oliveira Conterno L. Audit of antibiotic use in a Brazilian University Hospital. Braz J Infect Dis 2004;8:272-80.
de Castro MS, Pilger D, Ferreira MB, Kopittke L. Trends in antimicrobial utilization in a University Hospital, 1990-1996. Rev Saude Publica 2002;36:553-8.
Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 2003;31:208-15.
Peto Z, Benko R, Matuz M, Csullog E, Molnar A, Hajdu E. Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in Hungary. Infection 2008;36:560-4.
Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Impact of intensive care unit (ICU) drug use on hospital costs: A descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003;31 1 Suppl: S17-24.